The Organic Chemistry of Drug Synthesis

The Organic Chemistry of Drug Synthesis, Volume 5 covers the literature on the synthesis of medicinal agents from 1988-1993. This well-received series meets the needs of practitioners in the field who seek a quick overview of the synthetic routes that have been used to access specific classes of therapeutic agents. While most books on medicinal chemistry are organized on the basis of therapeutic or biochemical classes, materials in this series are arranged and discussed in terms of chemical structure. Thus, the preparation and detailed organic chemistry of the classes are presented in a unified way. Only drugs which have been granted a U.S. Adopted Name are included in this series. Synthetic organic, pharmaceutical, medicinal, and heterocyclic chemists will find this series an invaluable resource for their research in the synthetic chemistry of drug development. DANIEL LEDNICER is a chemist with the National Cancer Institute He received his PhD in organic chemistry from Ohio State University. He is the author or coauthor of the previous four volumes in the Wiley series, The Organic Chemistry of Drug Synthesis. He is also Series Editor of Chemistry and Pharmacology of Drugs, published by Wiley.